A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
Shigeji Matsubara(University of Virginia), Leland W.K. Chung(VA Palo Alto Health Care System), Thomas A. Gardner(Indiana University), Jay Y. Gillenwater(University of Virginia), Chia‐Ling Hsieh(Taipei Medical University Hospital), Yoshitaka Wada(University of Virginia), Moon Soo Park(Sungkyunkwan University), Masayuki Egawa(University of Virginia), Sadao Kamidono(Red Cross Hospital), Haiyen E. Zhau(Cedars-Sinai Medical Center), Chinghai Kao(University of Virginia)
PubMed
August 15, 2001
Cited by 149
Related Papers
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
|PubMed|1994|739
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
|Nature Protocols|2007|520
Insulin-like Growth Factor-I–Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
|Cancer Research|2008|384
MOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENT
|The Journal of Urology|2005|363